) I A T H ( H b m G t s e v n I & e d a r T n e s s e H © Bavaria International German-Chinese Working Group for the Health and Medical Industry The "German-Chinese Working Group for the Promotion of the Health and Medical Industry" was founded at MEDICA 2021. With this contract, the project for cooperation between German players and partners from the life science sector in China was brought to life. It aims to harness the diverse opportunities and potentials for companies in the life science environment. Chinese and German companies are to receive support in expanding their activities in the other country. The focus is primarily on professional exchange and cooperation between companies in both countries and in science and research, as well as on industrial investments. Nine partners from Germany are involved Representatives of the working group members signing the contract at MEDICA 2021. The working group is led by CIPA (China Investment Promotion Agency of Ministry of Commerce of P. R. China) and Germany Trade & Invest, the German foreign trade promotion agency. Also participating from the German side are BioM, BioCon Valley, BIO.NRW, Hessen Trade & Invest, Life Science Nord, Medical Valley, medways and WTSH (Wirtschaftsförderung und Technologietransfer Schleswig-Holstein). Read more… Greater Bay Area Seminar Series: Medical Diagnostics and Testing Another seminar within the Greater Bay Area Seminar Series has gathered participants from Europe and China and featured 7 international speakers and 5 discussion panels with the focus on medical diagnostics and testing ecosystems. The event took place online on 25th of November and was organized by the Huangpu, Guangzhou Development District’s office in Europe in partnership with the leading European healthcare clusters: BioM, BioRN, BioCon Valley, Biocat, Medical Valley, Life Science Nord, MAGIA2Market – European biotech alliance as well as with the support from POM Limburg, Catalonia Trade & Investment/Barcelona, and SCI Group/Guangzhou. The seminar’s focus was on medical diagnostics and testing ecosystem in China’s Greater Bay Area. The seminar has attracted European, Chinese but also Asia-wide healthcare & biomedicine SMEs and startups, as well as biomedicine clusters and investment promotion agencies both from China and Europe. In her opening speech, Yu Chen, who is from Guangzhou and Manager China Desk at POM Limburg, Belgium underlined strategic importance of thriving economic cooperation relationship between China and Europe. Bavarian Biotech News, December 2021 www.bio-m.org 9